Jesper Hallas

Medicin og biovidenskab

1. Denmark 100%
2. Prescriptions 80%
3. Pharmaceutical Preparations 65%
4. Cohort Studies 64%
5. Case-Control Studies 63%
6. Confidence Intervals 52%
7. Registries 51%
8. Population 49%
9. Odds Ratio 45%
10. Hydroxymethylglutaryl-CoA Reductase Inhibitors 36%
11. Mortality 32%
12. Drug Utilization 31%
13. Databases 28%
14. Anti-Inflammatory Agents 23%
15. Vitamin K 22%
16. Hemorrhage 22%
17. Anticoagulants 22%
18. Therapeutics 20%
19. Incidence 18%
20. Prescription Drugs 18%
21. Aspirin 18%
22. Stroke 18%
23. Delivery of Health Care 17%
24. Propensity Score 16%
25. Atrial Fibrillation 16%
26. Proton Pump Inhibitors 16%
27. Cerebral Hemorrhage 15%
28. Serotonin Uptake Inhibitors 15%
29. Comorbidity 14%
30. Chronic Obstructive Pulmonary Disease 14%
31. phthalic acid 14%
32. Myocardial Infarction 14%
33. SARS Virus 14%
34. Antidepressive Agents 13%
35. Peptic Ulcer 13%
36. Medication Errors 13%
37. Muscarinic Antagonists 13%
38. Neoplasms 12%
39. Overactive Urinary Bladder 11%
40. Sweden 11%
41. Observational Studies 11%
42. Logistic Models 11%
43. Scandinavian and Nordic Countries 11%
44. Information Storage and Retrieval 11%
45. Metformin 11%
46. Anti-Bacterial Agents 11%
47. Pharmacists 11%
48. Warfarin 11%
49. Colorectal Surgery 10%
50. Randomized Controlled Trials 10%